EN DE

Solbar Ningbo Protein Technology Co (603231) Fair Value & Analysis

Consumer Defensive · CN · Market cap 2.9B CNY

SN Solbar Ningbo Protein Technology Co 603231 · SHG
Price¥15.66
Fair Value¥18.64
Upside+19.0%
Quality50/100
Watch Solbar Ningbo Protein Technology Co for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 9.6% net margin
generates free cash flow
2.35% dividend yield
Ranks above peers (9/13)
Moderate moat 45/100
Evidence: High Range ¥11.47 – ¥24.77 Share as image

Fair value as of: Jul 11, 2026

From 26 valuation models · updated 30 days ago

Share price +3.0% over the past month.

A solid business, screening 19% undervalued on our models.

What matters now

  • A fairly wide model range (¥11.47 to ¥24.77) leaves room in how you read the outcome.
  • Our model range runs from ¥11.47 (bear) to ¥24.77 (bull), base ¥18.64. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 50/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (3 years)

¥26.53 ¥13.48 Fair Value ¥18.64 Dec 2023 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 11, 2026.

How to read this chart

32‑month range ¥13.48 – ¥26.53 · fair‑value band ¥11.47 – ¥24.77 · the ¥15.66 price screens below the ¥18.64 fair value. Dashed = 300-day average. As of Jul 11, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Solbar Ningbo Protein Technology Co (603231) currently trades at ¥15.66, while our model-based Fair Value estimate is ¥18.64, implying the stock looks roughly 19.0% undervalued today. The Quality Score stands at 50/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Solbar Ningbo Protein Technology Co generated revenue of 1.8B CNY at a net margin of 9.6%. Revenue grew 24.4% year over year. It earns a return on equity of 9.0%. The balance sheet holds a net cash position of 296M CNY. Fundamentals as of Jul 11, 2026

Our scenario range runs from ¥11.47 (bear case) to ¥24.77 (bull case); at ¥15.66, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 30% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 19%, 603231 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income ¥8.94 ¥9.79 ¥13.21 76
Growth DCF ¥8.30 ¥11.72 ¥16.50 72
Gordon GGM ¥2.64 ¥5.26 ¥7.96 70
All 26 models by family
DCF Models
FCF DCF ¥8.23 ¥12.18 ¥18.11 38
Owner Earnings ¥5.76 ¥8.31 ¥12.14 31
5Y Revenue Exit ¥10.15 ¥16.27 ¥24.23 39
5Y EBITDA Exit ¥12.45 ¥20.65 ¥30.40 41
5Y P/E Exit ¥12.29 ¥20.34 ¥28.97 38
10Y Revenue Exit ¥9.05 ¥14.42 ¥21.89 36
10Y EBITDA Exit ¥10.81 ¥17.42 ¥26.57 37
10Y P/E Exit ¥10.71 ¥17.21 ¥25.49 35
Earnings-Based
Graham-Dodd ¥6.74 ¥22.85 ¥30.63 54
Lynch FV ¥5.23 ¥7.47 ¥9.71 50
PEG = 1.0 ¥5.23 ¥7.47 ¥9.71 46
EPV ¥10.55 ¥12.02 ¥13.29 59
Dividend Discount
Gordon GGM ¥2.64 ¥5.26 ¥7.96 70
DDM Multi-Stage ¥2.64 ¥4.46 ¥5.55 61
Multiples
P/E Multiple ¥14.86 ¥19.82 ¥24.77 63
P/S Multiple ¥12.63 ¥16.85 ¥21.06 58
P/B Multiple ¥12.63 ¥16.85 ¥21.06 55
EV/EBIT ¥16.68 ¥21.82 ¥26.96 53
EV/EBITDA ¥16.39 ¥21.44 ¥26.48 54
EV/Revenue ¥11.65 ¥16.11 ¥20.56 43
Asset-Based
NCAV (Graham) ¥5.24 ¥7.02 ¥10.48 50
Growth DCF
Growth DCF ¥8.30 ¥11.72 ¥16.50 72
Rev-Margin DCF ¥10.15 ¥16.19 ¥23.26 67
Economic Profit
Residual Income ¥8.94 ¥9.79 ¥13.21 76
ROIC Compounder ¥10.57 ¥12.94 ¥15.99 67
Growth Earnings
Growth-Adj P/E ¥12.74 ¥18.21 ¥23.67 68

Widest divergence: Growth Earnings (¥18.21) versus Dividend Discount (¥4.46). Highest evidence: Residual Income (76).

Notify me when 603231 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 1.8B CNY
Revenue growth (YoY) +24.4%
Net margin 9.6%
Return on equity 9.0%
Free cash flow 121M CNY FY2025
P/E ratio 16.4
More key figures
Operating margin 8.2%
EPS (TTM) ¥0.9300
Dividend yield 2.4%
EPS growth (YoY) -26.1%
Net cash 296M CNY FY2024

Figures from reported company fundamentals · as of Jul 11, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 50/100

Of which business quality 53 · Market factors (momentum, volatility) 40

Profitability 45
Margins and returns on capital today
Quality Growth 63
Are margins and returns improving?
Cashflow 47
Earnings quality: real cash, not paper profit
Fin. Strength 87
Balance sheet, leverage, solvency risk
Investment 17
Disciplined investing over empire-building
Low Volatility 82
Calm price path (market factor)
Momentum 25
Price trend over the last 3–12 months (market factor)
52W Momentum 16
Distance to the 52-week high (market factor)
Net Issuance 42
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Solbar Ningbo Protein Technology Co., Ltd. engages in the research and development, production, and sale of soybean protein products in China and internationally.

Full company description

Solbar Ningbo Protein Technology Co., Ltd. engages in the research and development, production, and sale of soybean protein products in China and internationally. It offers functional and textured soy protein concentrates, textured soy proteins, textured fibrous vegetable proteins, isolated soy proteins, defatted soy flours, and non-GMO soybean oil, which are widely used in food, health products, plant-based food, pharmaceutical fermentation, pet food and other fields. The company provides products through its network of distributors, as well as through direct sales to multinational customers. Solbar Ningbo Protein Technology Co., Ltd. was founded in 2003 and is based in Ningbo, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Solbar Ningbo Protein Technology Co reported revenue of ¥1.7B in FY2025 versus ¥1.6B in FY2021, a compound +2.5%/yr. Reported net income was ¥190M in FY2025, compounding +11.2%/yr from FY2021.

Growth Quality 67/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
1.7B CNY
Latest YoY
+12.4%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.5%
Avg. growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.6%
Revenue +2.5%/yr
FY21 ¥1.6B
FY22 ¥1.8B
FY23 ¥1.7B
FY24 ¥1.6B
FY25 ¥1.7B
Net income +11.2%/yr
FY21 ¥124M
FY22 ¥168M
FY23 ¥146M
FY24 ¥121M
FY25 ¥190M

Watch 603231: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Solbar Ningbo Protein Technology Co Fair Value". https://www.fairvalue-calculator.com/stock/603231

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 50 · Below median
Fair Value upside +19% · Above median
Return on equity (TTM) 9% · Above median
Return on assets 6% · Above median
Net margin (TTM) 10% · Top 25%
Operating margin (TTM) 8% · Above median
Revenue growth 24% · Top 25%
Dividend yield (TTM) 2.4% · Above median

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 16.4× · Cheaper than median
P/B 1.45× · Cheaper than median
P/S (TTM) 1.58× · Pricier than median
P/FCF 3.6× · Pricier than median
EV/EBITDA 9.5× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 59 · sector 28
FUTURE 100 · sector 20
PAST 36 · sector 27
HEALTH 0 · sector 96
DIVIDEND 47 · sector 47

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,427 ₹362.37 -75%
Britannia Industries Limited BRITANNIA ₹5,413 ₹1,870 -65%
Tata Consumer Products Limited TATACONSUM ₹1,089 ₹327.27 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,650 IDR 15,757 IDR +137%
Samyang Foods Co 003230 1,139,000 KRW 1,010,543 KRW -11%
Patanjali Foods Limited PATANJALI ₹413.80 ₹157.04 -62%
Vietnam Dairy Products Joint Stock Company VNM 58,500 VND 68,259 VND +17%
PT Mayora Indah Tbk, MYOR 1,750 IDR 2,699 IDR +54%
PT Cisarua Mountain Dairy Tbk CMRY 4,490 IDR 4,355 IDR -3%
Nongshim Co 004370 348,500 KRW 530,619 KRW +52%

Compare Solbar Ningbo Protein Technology Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Solbar Ningbo Protein Technology Co (603231) overvalued or undervalued?
As of Jul 11, 2026, our model estimates a fair value of ¥18.64 versus a price of ¥15.66, about +19% (undervalued).
What is the fair value of 603231?
Our model-based fair value for Solbar Ningbo Protein Technology Co is ¥18.64 (as of Jul 11, 2026), built from audited fundamentals. The current price is ¥15.66.
What is the quality score of 603231?
Solbar Ningbo Protein Technology Co has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Solbar Ningbo Protein Technology Co (603231)?
Solbar Ningbo Protein Technology Co reported trailing-twelve-month revenue of about 1.8B CNY (latest available figure, as of Jul 11, 2026).
What is the net profit margin of 603231?
The net profit margin of Solbar Ningbo Protein Technology Co is about 9.6%, meaning it keeps roughly 9.6% of revenue as net income. Based on the latest reported figures.
Does Solbar Ningbo Protein Technology Co pay a dividend?
Solbar Ningbo Protein Technology Co currently shows a dividend yield of about 2.35% relative to its recent price (as of Jul 11, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Solbar Ningbo Protein Technology Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.